FDA approves Sanofi daily MS pill
September 13 2012
The move expands patient options, but industry watchers tell MM&M it's not going to spur a radical change in treatment.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.